Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III‐D Report: Multi Criteria Decision Analysis
Journal Articles
Overview
Research
Identity
Additional Document Info
View All
Overview
abstract
BackgroundThe 2023 ACR/EULAR Antiphospholipid Syndrome (APS) Classification Criteria development, aiming to identify patients with high likelihood of APS for research, employed a four‐phase methodology. Phase I and II resulted in 27 proposed candidate criteria, organized into laboratory and clinical domains. Here, we summarize the last stage of Phase III efforts employing a consensus‐based multi‐criteria decision analysis (MCDA) to weigh candidate criteria and identify an APS classification threshold score.MethodsWe evaluated 192 unique, international real‐world cases referred for “suspected APS” with a wide range of APS manifestations. Using proposed candidate criteria, subcommittee members rank‐ordered 20 representative cases from highly unlikely to highly likely APS. During an in‐person meeting, the subcommittee refined definitions and participated in an MCDA exercise to identify relative weights of candidate criteria. Using consensus decisions and pairwise criteria comparisons, 1000Minds™ software assigned criteria weights, and we rank ordered 192 cases by their additive scores. A consensus‐based threshold score for APS classification was set.ResultsPre‐meeting evaluation of 20 representative cases demonstrated variability in APS assessment. MCDA resolved 81 pairwise decisions; relative weights identified domain item hierarchy. After assessing 192 cases by weights and additive scores, the Steering Committee reached consensus that APS classification should require separate clinical and laboratory scores, rather than a single aggregate score, to ensure high specificity.ConclusionUsing MCDA, candidate criteria preliminary weights were determined. Unlike other disease classification systems using a single aggregate threshold score, separate clinical and laboratory domain thresholds were incorporated into the new APS classification criteria.
